HRT Financial’s Cardlytics CDLX Stock Holding History

HRT Financial’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70K	Buy	15,610 +970	+7%	+$7.25K	﹤0.01%	3699
2026 Q1	$153K	Buy	+14,640	New	+$143K	﹤0.01%	3260
2025 Q3	–	Sell	-9,683	Closed	-$159K	–	2917
2025 Q2	$159K	Buy	+9,683	New	+$167K	﹤0.01%	2122
2024 Q1	–	Sell	-9,254	Closed	-$852K	–	2385
2023 Q4	$852K	Buy	+9,254	New	+$941K	0.01%	1072
2021 Q3	–	Sell	-918	Closed	-$1.17M	–	3319
2021 Q2	$1.17M	Buy	+918	New	+$1.04M	0.01%	923

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial's CDLX Position: Q2 2026 in Review

HRT Financial increased its Cardlytics (CDLX) stake by 6.6% in Q2 2026, buying an estimated $7.25K and bringing the position to 15,610 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #3699.

HRT Financial first reported a position in CDLX in Q2 2021 and has held it in 5 quarters since. The position peaked at $1.17M in Q2 2021. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

HRT Financial held 15,610 shares of Cardlytics worth $70K as of Q2 2026.
HRT Financial bought 970 Cardlytics shares in Q2 2026, an estimated $7.25K.
Cardlytics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3699 holding.
HRT Financial first reported a position in Cardlytics in Q2 2021 and has held it in 5 quarters since.
HRT Financial's Cardlytics position peaked at $1.17M in Q2 2021.
42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.